Physician profile
Sergey Neckrysh
NPI 1285736637
$1,586,705.17
in general payments reported to CMS, 2019-2025
11 companies · $355K in 2025
The $355K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79K · 2020: $138K · 2021: $204K · 2022: $190K · 2023: $3,203 · 2024: $617K · 2025: $355K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $925K · Consulting Fee: $28K · Travel and Lodging: $19K · Food and Beverage: $2,757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $924,999.91 |
| Consulting Fee | $28,455.57 |
| Travel and Lodging | $18,930.72 |
| Food and Beverage | $2,757.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,476,864.59 | 2019-2025 | Yukon Oct Spinal System, Everest Spinal System |
| Alphatec Spine, INC | $49,407.94 | 2023-2025 | Other - Miscellaneous, Invictus Mis, Identiti |
| Surgalign Spine Technologies, INC. | $47,249.43 | 2021-2022 | |
| Globus Medical, INC. | $10,363.05 | 2019 | |
| Baxter Healthcare | $1,680.00 | 2020 | |
| Xtant Medical INC | $368.94 | 2023-2024 | |
| Acuity Surgical Devices, LLC | $332.53 | 2019 | |
| Medtronic USA, INC. | $173.24 | 2019 | |
| Highridge Medical LLC | $123.34 | 2024 | Mobi-C Plug & Fit US |
| Medtronic, INC. | $116.54 | 2021 | |
| Djo, LLC | $25.57 | 2023 | Cmf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Neckrysh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.